Cantor Fitzgerald Reiterates Overweight on Trulieve Cannabis, Maintains $15 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 83.1%

Neg 0% Neu 83.1% Pos 0%

Cantor Fitzgerald analyst Gabie Ingoglia reiterates Trulieve Cannabis (NYSE:TRLV) with a Overweight and maintains $15 price target.